TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international audience of biologists and clinicians, including those still in training. Chairs: Pierre Fenaux, Katharina Götze, Mikkael Sekeres

Date: Friday 12 - Sunday 14 April 2024
Venue: Budapest Marriott Hotel, Budapest

This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease. New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.

Posters and Brief Oral Communications
Registered participants are invited to submit their abstracts. Selected abstracts are eligible for an oral or a poster presentation. Call for abstracts: deadline 15 January 2024.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in training

Learning Objectives
Upon completion of this CME activity, participants should be able to:

  • Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis.
  • Improve ability to analyse prognostic factors, including new ones (revised IPSS, molecular analysis).
  • Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
  • Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.
  • Scientific Topics
    The sinister origins of MDS
  • The interplay between MDS, inflammatory, and immune abnormalities
  • What's in a name? Classifying MDS
  • New tools to explore MDS
  • Special populations
  • Treatment of lower-risk MDS
  • Treatment of higher-risk MDS
  • Transplantation
  • Clinical trials in MDS/CMML: cooperative groups

The program will include:

  • Plenary Sessions
  • Panel Discussions
  • Simultaneous Meet the Expert Sessions
  • Poster Walks
  • Brief Oral Communications

For further information and to register for the event please visit the conference website

External Events

Apr 24
May 24
Sep 24
April 22nd 2024
BGS Transfusion
BGS Transfusion is a three-day symposium aimed at all levels of staff working in blood transfusion.
May 10th 2024
Haematology Patient and Carers Congress
This event is directed at patients and carers affected by haematological disorders. Whether affected by a condition l...
May 21st 2024
UCLH 'Caring for the Critically Ill Haematology...
UCLH’s 2024 Caring for the Critically Ill Haematology Patient Study Day is now open for registration. Topics include:...
Location: Online Event
September 23rd 2024
Haematology in Obstetrics course 2024
The Haematology in Obstetrics course aims to develop an understanding of the physiology and pathology of obstetric ha...
Location: St Edmund Hall, Oxford University